TickerFactsScreenerDevelopers

IMMUNIC, INC. (IMUX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $803.0K2012: $4.48M2013: $38.19M2014: $102.24M2015: $83.42M2016: $59.99M2017: $56.90M2018: $13.07M2019: $29.37M2020: $127.45M2021: $86.86M2022: $106.75M2023: $46.67M2024: $35.67M2025: $15.48M$15.48M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$15.48M-56.6%
2024$35.67M-23.6%
2023$46.67M-56.3%
2022$106.75M+22.9%
2021$86.86M-31.8%
2020$127.45M+334.0%
2019$29.37M+124.7%
2018$13.07M-77.0%
2017$56.90M-5.2%
2016$59.99M-28.1%
2015$83.42M-18.4%
2014$102.24M+167.7%
2013$38.19M+752.9%
2012$4.48M+457.5%
2011$803.0K—